At the request of Gabather AB, equity rights TO 5 will be traded on First North
as from 16 January 2024.
Security name: Gabather TO 5
-----------------------------
Short name: GABA TO 5
-----------------------------
ISIN code: SE0021149705
-----------------------------
Orderbook ID: 318562
-----------------------------
Terms: The warrants of series TO 5 will be issued free of charge and will be
available for subscription of new shares during the period 11 April
2024 - 25 April 2024. One (1) warrant gives the right to subscribe for
one (1) new share in the Gabather AB at an exercise price corresponding
to 70 percent of the volume-weighted average price paid for the
Gabathers AB's share on Nasdaq First North Growth Market during the
period 15 March 2024 - 8 April 2024, however not less than SEK 1.3 and
not more than SEK 3.00 per share.
--------------------------------------------------------------------------------
Subscr 11 April 2024 - 25 April 2024
iption
perio
d:
--------------------------------------------------------------------------------
Last 23 April 2024
tradi
ng
day:
--------------------------------------------------------------------------------
This information is distributed at the request of the Certified Adviser,
Corpura Fondkommission AB. For further information, please call Corpura
Fondkommission AB on +4672-252 34 51.Nasdaq Stockholm AB: New equity right for trading, Gabather TO 5 (24/24)
© 2024 GlobeNewswire
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 10.04. | Gabather AB: Gabather Joins Forces with the Centre for Neuropsychiatric Schizophrenia Research in Denmark to Conduct a Clinical Phase II Study with GT-002 | STOCKHOLM, April 10, 2024 /PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) announces that the Company has signed a Collaborative Agreement with the Centre for Neuropsychiatric... ► Artikel lesen | |
| 18.03. | Gabather AB: Gabather files two new patent applications to secure novel findings on the effects of GT-002 for the treatment of psychiatric disorders | STOCKHOLM, March 18, 2024 /PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) today reports that two new US provisional patent applications based on novel findings from the... ► Artikel lesen | |
| 07.03. | Gabather AB: Gabather reports initial positive results from the EEG/fMRI target engagement study | STOCKHOLM, March 7, 2024 /PRNewswire/ -- Gabather AB (Nasdaq First North Growth Market: GABA) today reports initial positive results from the EEG/fMRI target engagement study, a double-blinded... ► Artikel lesen | |
| 15.01. | Nasdaq Stockholm AB: New equity right for trading, Gabather TO 5 (24/24) | At the request of Gabather AB, equity rights TO 5 will be traded on First North
as from 16 January 2024.
Security name: Gabather TO 5
-----------------------------
Short name: GABA TO 5
-----------------------------
ISIN... ► Artikel lesen | |
| 09.01. | Nasdaq Stockholm AB: Last day of trading in paid subscription units (BTU) of Gabather AB (publ) (12/24) | Trading in Gabather AB paid subscription units is to cease. The last trading
day is January 10, 2024.
Short name: GABA BTU
ISIN code: SE0021149721
Orderbook ID: 313990
This information is distributed... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen.
Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen,
bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen
Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu
verstehen sein kann.
